Alcobra

Bio Pharma Company Selling ADHD Medication Based in Tel Aviv

About us Alcobra Ltd., founded in 2008 and headquartered in Tel Aviv, Israel, is an emerging pharmaceutical company focused on the development of new medications to help patients with central nervous system disorders. The company’s lead investigational product candidate is an abuse deterrent formulation of amphetamine immediate release (ADAIR) for the treatment of ADHD.

Relationships Interlocks Giving Data

Leadership & Staff

David Baker-Philadelphia Interim CEO Alcobra Pharmaceutical Company

• Interim CEO ('17→?)

David Baker President Vallon Pharmaceuticals

• Former Chief Commercial Officer ('14→'17)*

Updated over 5 years ago

Types	Organization
Start date	2008

Alcobra

Bio Pharma Company Selling ADHD Medication Based in Tel Aviv

Leadership & Staff

Basic Info

Source Links